Agenus declares dividend of 5M shares of MiNK Therapeutics to shareholders

AGENUS INC

Record date April 17, 2023; payment no earlier than April 27 and no later than May 17, 2023.
Pro rata distribution; no fractional shares; cash in lieu based on MiNK closing price on record date.
CEO Garo Armen says dividend demonstrates commitment to delivering additional shareholder value.
MiNK to present updated clinical data for agenT-797 at AACR Annual Meeting April 14-19, 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.